Ulcerative colitis and multiple sclerosis are two autoimmune conditions. People with ulcerative colitis may be at an increased risk of multiple sclerosis, but the opposite doesn’t seem to be true.
Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of ...
In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...
Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...
PORTLAND, OR, UNITED STATES, February 7, 2025 /EINPresswire / -- The global ulcerative colitis (UC) market is ex ...
To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and ...
Bengaluru: Equillium, Inc., a clinical-stage biotechnology company and Biocon Limited, an innovation-led global ...
Your immune system is a complicated network designed ... There are several treatments for ulcerative colitis (UC), including JAK inhibitors. JAK inhibitors are a type of medication to manage ...
Equillium and Biocon announce positive data from phase 2 study of itolizumab to treat moderate to severe ulcerative colitis: Our Bureau, Bengaluru Friday, February 7, 2025, 10:30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback